Form 4: HCA Healthcare CEO Samuel Hazen Acquires Stock Appreciation Rights
SEC Form 4 Filing
HCA Healthcare CEO Samuel Hazen was granted 74,620 stock appreciation rights on January 28, 2025, which vest in four equal annual installments starting January 28, 2026.
Summary
- HCA Healthcare's CEO, Samuel Hazen, acquired 74,620 stock appreciation rights on January 28, 2025.
- These rights have an exercise price of $328.70.
- The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.
- The rights expire on January 28, 2035.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management and shareholder interests. There are no negative implications.
Positives
- The grant of stock appreciation rights aligns the CEO's interests with those of the shareholders.
- The vesting schedule encourages long-term performance and retention of the CEO.
Future Outlook
The stock appreciation rights vest over four years, incentivizing the CEO to focus on long-term value creation.
Industry Context
Stock appreciation rights are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Stock appreciation rights are a standard form of equity compensation for executives in publicly traded companies, including those in the healthcare sector.
- Companies like Tenet Healthcare and Universal Health Services also use similar equity-based incentives for their top executives.
- The vesting schedule of four years is also typical for such grants, encouraging long-term performance.
Stakeholder Impact
- The stock appreciation rights grant is intended to align the CEO's interests with those of the shareholders, potentially leading to increased shareholder value.
- The vesting schedule may encourage the CEO to focus on long-term strategic goals.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Date of the stock appreciation rights transaction. |
| 01/28/2026 | First vesting date of the stock appreciation rights. |
| 01/28/2035 | Expiration date of the stock appreciation rights. |
| 01/30/2025 | Date the form was signed. |
Keywords
Stock Appreciation Rights, HCA Healthcare, CEO, Samuel Hazen, Executive Compensation, Equity Grant, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.